Aller au contenu
Global sound
Telltales

Telltales

Value Hiding in Plain Sight

· 28 min

Notes d’épisode

Hormuz risk pushes Hunt’s oil call toward $80 (not $90–100), the team hunts for value on a high market — and lands on hyperscaler infrastructure over AI models — while healthcare delivers the first MRD-guided cancer approval and a live UNH margin-recovery setup.
The Cashflow Memo
Key Takeaways
* Hunt on Hormuz: a multi-week/month US–Iran stalemate keeps crude closer to $80 than $65 (not $90–100); producers still budget off the 2027 strip, so higher spot just widens backwardation rather than spurring rig activity.
* Value on page one of the memo: Amazon, Microsoft (~20x earnings), and Google/Alphabet (~30x) look reasonable once hyperscaler CapEx is treated as optional and data-center replacement cost is priced as a real asset; Jason argues models are commoditizing and the durable value is token infrastructure (Amazon Trainium + hosting overlooked).
* Oracle near a 52-week low after the OpenAI capacity commitment and ~$110B net debt looks more value trap than bargain; IBM’s mainframe weakness this week is a signal that legacy IT budgets are being redirected to AI, and the hosts float that canceled OpenAI deals could be equity-accretive if capacity re-contracts on the open market.
* Memory inflation (gigawatt DC cost maybe doubled) is the live constraint on Nvidia: if hyperscaler CapEx does not re-rate another 30–40%, chip budgets get crowded out even if token demand stays strong; TSMC’s $60B CapEx year still screens cheap net of Taiwan political risk.
* Healthcare: first FDA approval of a cancer treatment gated on an MRD (molecular residual disease) blood test (Roche/Genentech, bladder) validates the MRD-supplier thesis; UNH expected to show margin bounce on high-20s/low-30s premium hikes; BioNTech preferred over Moderna on cash discipline; Vertex’s non-opioid pain drug is inflecting as PBM formulary frictions ease; Harrow’s Q1 CVS co-pay buy-down error (negative revenue on formulary patients) is the near-term watch item.
Show Notes
[00:00:00] Intro & Welcome Mike opens Telltales; grab this week’s Cash Flow Memo at telltales.us.
[00:00:26] Exhibits A–C: Deficit, Hormuz & Oil Structure Hunt frames a multi-week Hormuz stalemate as closer-to-$80 crude with wider backwardation, producers still deciding off the 2027 strip; Exhibit A deficit runs roughly flat YoY through May, and any eventual sovereign-credit discipline will hit healthcare first.
[00:04:34] Where Is the Value? Hyperscalers on Page One Mike and Jason make the case for Amazon, Microsoft (~20x), and Google (~30x) as infrastructure bets: CapEx is optional, replacement cost of installed data centers is high, and OpenAI lease stress only reinforces that tokens-and-capacity — not the model layer — is where value accrues. Amazon’s Trainium and hosting playbook get special attention.
[00:08:24] Oracle: Cheap or Value Trap? Near a 52-week low with ~$110B net debt and heavy OpenAI-linked CapEx, Oracle draws a Charter-style leverage caution; IBM’s mainframe weakness is read as AI budget…

Site web: telltales.substack.com

En direct, dernière heure : 7 461 titres sur 3 158 stations dans 126 pays

Découvrez le monde par la radio

Plus de façons de découvrir (9)

Vous avez entendu quelque chose de bien ? Enregistrez-le, ou ouvrez-le directement dans Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
NoviraContinuer l’écoute